Herve Hoppenot

Track

Insider profile

Currently holds positions in Incyte Corp and Cellectis SA

Performance

Overall performance
2.8
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 36%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chairman of the Board, President, Chief Executive Officer Incyte Corp May 1, 2015 -
Non-Executive Independent Director Cellectis SA June 26, 2017 -
President, Chief Executive Officer, Director Incyte Corp Jan. 13, 2014 - May 1, 2015
Herve Hoppenot's trades of Incyte Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-12 2025-11-10
US Incyte Corp (INCY)
S Sale
57,616 -1.7%
480.44
US$1,343,810 		57,616 -1.7% 480.44 US$1,343,810
2025-11-10 2025-11-10
US Incyte Corp (INCY)
PrS Proposed sale
29,568
318.91
US$2,982,712 		29,568 318.91 US$2,982,712
2021-02-23 2021-02-23
US Incyte Corp (INCY)
B Purchase
60,489 -46.8%
149.66
US$785,486 		60,489 -46.8% 149.66 US$785,486
2020-07-07 2020-07-07
US Incyte Corp (INCY)
PlS Planned sale
88,406 -24.9%
110.00
US$9,724,660 		88,406 -24.9% 110.00 US$9,724,660
2020-07-07 2020-07-07
US Incyte Corp (INCY)
PlS Planned sale
1,365 -0.5%
110.00
US$150,150 		1,365 -0.5% 110.00 US$150,150